PBIGF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Paradigm Biopharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.1204 USD Market Closed

Market Cap: $42.2m

P	Paradigm Biopharmaceuticals Ltd OTC:PBIGF	AU
B	Bombardier Inc XBER:BBDB	CA
A	Ananda Development PCL SET:ANAN	TH
C	Cognex Corp F:CGZ	US
R	Rocket Companies Inc XBER:RC5	US
	Krispy Kreme Inc NASDAQ:DNUT	US
	Companhia Energetica de Brasilia CEB BOVESPA:CEBR3	BR

Profitability Summary

Paradigm Biopharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

100%

Gross Margin is Increasing

99% > 100%

Negative Operating Margin

-495%

Negative 3Y Average Operating Margin

-563%

Operating Margin is Increasing

-496% > -495%

Negative Net Margin

-519%

Negative 3Y Average Net Margin

-574%

Declining Net Margin

-495% > -519%

Negative Free Cash Flow Margin

-230%

Negative 3Y Average Free Cash Flow Margin

-672%

Free Cash Flow Margin is Increasing

-373% > -230%

Negative ROE

-180%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2.081%

ROIC is Increasing

-953% > -492%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

100%

Gross Margin is Increasing

99% > 100%

Negative Operating Margin

-495%

Negative 3Y Average Operating Margin

-563%

Operating Margin is Increasing

-496% > -495%